Veeva Systems Director Sells $115K in Stock

Priscilla Hung, a director at the cloud software company, disclosed the sale of 750 shares.

Apr. 15, 2026 at 9:22am

Got story updates? Submit your updates here. ›

A photorealistic studio still life featuring a stack of financial documents, a pen, and a calculator arranged elegantly on a clean, monochromatic background, conceptually representing the abstract corporate strategy and finance behind a recent insider transaction at Veeva Systems.A Veeva Systems director's stock sale raises questions about the company's short-term outlook, even as it remains a leader in life sciences software.Pleasanton Today

Veeva Systems Inc. (NYSE:VEEV) Director Priscilla Hung sold 750 shares of the company's stock on April 10th at an average price of $153.50, for a total value of $115,125. The sale represented a 15.78% decrease in Hung's ownership stake in Veeva Systems, which she now holds 4,003 shares valued at $614,460.50.

Why it matters

Insider transactions, such as stock sales by company directors, can provide insights into market sentiment and management's views on the company's prospects. Veeva Systems is a leading provider of cloud-based software solutions for the life sciences industry, and this sale by a board member may signal some uncertainty about the company's short-term performance.

The details

The stock sale was executed under a pre-arranged Rule 10b5-1 trading plan, which allows corporate insiders to schedule stock transactions in advance and avoid allegations of insider trading. Veeva Systems' shares have declined in recent months, falling from a 52-week high of $310.50 to the current trading price around $159.

  • The stock sale took place on Friday, April 10th, 2026.
  • Veeva Systems' shares opened at $159.09 on Wednesday, April 15th, 2026.

The players

Priscilla Hung

A director on the board of Veeva Systems Inc., a cloud software company that provides industry-specific applications and data solutions for the global life sciences sector.

Veeva Systems Inc.

A cloud software company that develops industry-specific applications and data solutions for the global life sciences sector, including pharmaceutical, biotechnology, medical device, and consumer health companies.

Got photos? Submit your photos here. ›

What’s next

Investors will be closely watching Veeva Systems' upcoming financial results and guidance to assess the company's performance and outlook.

The takeaway

This insider sale by a Veeva Systems director highlights the volatility in the company's stock price and the uncertainty surrounding its short-term prospects, despite its long-term growth potential in the life sciences software market.